Comparative effectiveness of peripheral vascular intervention versus surgical bypass for critical limb ischemia in the Vascular Study Group of Greater.

Slides:



Advertisements
Similar presentations
Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease  Joseph P. Archie, PhD, MD  Journal of Vascular.
Advertisements

Outcomes of cold-stored venous allograft for below-knee bypasses in patients with critical limb ischemia  Vincent Ziza, MD, Ludovic Canaud, MD, PhD, Thomas.
Multidisciplinary care improves amputation-free survival in patients with chronic critical limb ischemia  Jayer Chung, MD, J. Gregory Modrall, MD, Chul.
Carotid stenting versus endarterectomy in patients undergoing reintervention after prior carotid endarterectomy  Margriet Fokkema, MD, Gert Jan de Borst,
Autologous bone marrow mononuclear cell implantation therapy is an effective limb salvage strategy for patients with severe peripheral arterial disease 
Heart failure is associated with reduced patency after endovascular intervention for symptomatic peripheral arterial disease  Andrew J. Meltzer, MD, Gautam.
Favorable outcomes of very elderly patients with critical limb ischemia who undergo distal bypass surgery  Takuro Shirasu, MD, Katsuyuki Hoshina, PhD,
Monica S. O'Brien-Irr, MS, RN, Hasan H. Dosluoglu, MD, Linda M
Comparative effectiveness of endovascular versus open repair of ruptured abdominal aortic aneurysm in the Medicare population  Samuel T. Edwards, MD,
Prospective multicenter study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia  Louis L. Nguyen,
Outcome of infra-inguinal bypass grafts using vein conduit with less than 3 millimeters diameter in critical leg ischemia  Hani Slim, MD, MRCS, Alok Tiwari,
Statins are independently associated with reduced mortality in patients undergoing infrainguinal bypass graft surgery for critical limb ischemia  Andres.
IP181. Factors Affecting Limb Salvage Following Open and Endovascular Revascularization for Critical Limb Ischemia in a 10-Year Population-Based Study 
Jayer Chung, MD, David A. Timaran, MD, J
Open bypass and endovascular procedures among diabetic foot ulcer cases in the United States from 2001 to 2010  Grant H. Skrepnek, PhD, David G. Armstrong,
Increased warm ischemia time during vessel harvest decreases the primary patency of cryopreserved conduits in patients undergoing lower extremity bypass 
Dual antiplatelet therapy is associated with prolonged survival after lower extremity revascularization  Peter A. Soden, MD, Sara L. Zettervall, MD, MPH,
Impact of diabetes mellitus on outcomes of superficial femoral artery endoluminal interventions  Andrew M. Bakken, MD, Eugene Palchik, MD, Joseph P. Hart,
Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial  Jill.
Finnvasc score and modified Prevent III score predict long-term outcome after infrainguinal surgical and endovascular revascularization for critical limb.
Statin therapy is associated with superior clinical outcomes after endovascular treatment of critical limb ischemia  Francesco A. Aiello, MD, Asad A.
Favorable outcomes of very elderly patients with critical limb ischemia who undergo distal bypass surgery  Takuro Shirasu, MD, Katsuyuki Hoshina, PhD,
Outcomes of surgical management for popliteal artery aneurysms: An analysis of 583 cases  Owen N. Johnson, MD, Mark B. Slidell, MD, Robyn A. Macsata,
Predictive ability of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification system following infrapopliteal endovascular.
Presentation, treatment, and outcome differences between men and women undergoing revascularization or amputation for lower extremity peripheral arterial.
Long-term results of direct and indirect endovascular revascularization based on the angiosome concept in patients with critical limb ischemia presenting.
Impact of cilostazol after endovascular treatment for infrainguinal disease in patients with critical limb ischemia  Yoshimitsu Soga, MD, Osamu Iida,
Philip P. Goodney, MD, MS, Kerianne Holman, MD, MPH, Peter K
Clinical efficacy of endovascular therapy for patients with critical limb ischemia attributable to pure isolated infrapopliteal lesions  Osamu Iida, MD,
The consequences of an outbreak of multidrug-resistant Pseudomonas aeruginosa among patients treated for critical leg ischemia  Maria Söderström, MD,
Thrombolysis for lower extremity bypass graft occlusion
Katelynn M. Ferranti, MD, Turner M. Osler, MD, Reshma P
Validation of the PIII CLI risk score for the prediction of amputation-free survival in patients undergoing infrainguinal autogenous vein bypass for critical.
Outcomes of infrainguinal bypass determined by age in the Vascular Study Group of New England  Meghan Dermody, MD, MS, Christopher Homsy, MD, Yuanyuan.
Current accepted hemodynamic criteria for critical limb ischemia do not accurately stratify patients at high risk for limb loss  Raghuveer Vallabhaneni,
Perioperative outcomes and amputation-free survival after lower extremity bypass surgery in California hospitals, , with follow-up through 2004 
Outcomes of reinterventions after subintimal angioplasty
Clinical effects of single or double tibial artery revascularization in critical limb ischemia patients with tissue loss  Norihiro Kobayashi, MD, Keisuke.
The BASIL survival prediction model in patients with peripheral arterial disease undergoing revascularization in a university hospital setting and comparison.
Utility of direct angiosome revascularization and runoff scores in predicting outcomes in patients undergoing revascularization for critical limb ischemia 
Daniel J. Torrent, MD, MPH, Jill N. Zink, MD, William M. Bogey, MD, C
Syed N. Haider, Eamon G. Kavanagh, MD, Martin Forlee, FCS (SA), Mary P
In-hospital and 30-day outcomes after tibioperoneal interventions in the US Medicare population with critical limb ischemia  Todd R. Vogel, MD, MPH, Viktor.
Open versus endoscopic great saphenous vein harvest for lower extremity revascularization of critical limb ischemia  Vincent J. Santo, MD, Phong T. Dargon,
Abd Moain Abu Dabrh, MBBCh, MS, Mark W
Lower extremity autologous vein bypass for critical limb ischemia is not adversely affected by prior endovascular procedure  Vincent J. Santo, MD, Phong.
Current efficacy of open and endovascular interventions for advanced superficial femoral artery occlusive disease  Christopher J. Smolock, MD, Javier.
Comparison of open and endovascular treatment of patients with critical limb ischemia in the Vascular Quality Initiative  Jeffrey J. Siracuse, MD, Matthew.
Clinical consequence of bare metal stent and stent graft failure in femoropopliteal occlusive disease  Shant M. Vartanian, MD, Paul C. Johnston, MD, Joy.
James T. McPhee, MD, Philip P
Suggested objective performance goals and clinical trial design for evaluating catheter- based treatment of critical limb ischemia  Michael S. Conte, MD,
IP203. Initial Improvement in Ankle-Brachial Index After Vein Bypass for Rest Pain Predicts Limb Salvage  Senthil N. Jayarajan, Adrian C. Vlada, Michael.
Validation of the Society for Vascular Surgery's Objective Performance Goals for critical limb ischemia in everyday vascular surgery practice  Philip.
Sequential compression biomechanical device in patients with critical limb ischemia and nonreconstructible peripheral vascular disease  Sherif Sultan,
The consequences of an outbreak of multidrug-resistant Pseudomonas aeruginosa among patients treated for critical leg ischemia  Maria Söderström, MD,
Long-term assessment of cryopreserved vein bypass grafting success
SS3. Validation of the PIII CLI Risk Score for the Prediction of Amputation-Free Survival (AFS) in Patients with Critical Limb Ischemia  Andres Schanzer,
Composite sequential bypasses to the ankle and beyond for limb salvage
Joseph G. Magnant, MD, Jack L. Cronenwett, MD, Daniel B
Long-term prognostic factors after thrombolysis for lower limb ischemia  Monica Kuoppala, MD, Sofia Franzén, MD, Bengt Lindblad, MD, PhD, Stefan Acosta,
Regarding “Vascular abnormalities in patients with neurofibromatosis syndrome type I: Clinical spectrum, management, and results”  John B. Chang, MD,
Surgical and endovascular revision of infrainguinal vein bypass grafts: Analysis of midterm outcomes from the PREVENT III trial  Scott A. Berceli, MD,
Infrapopliteal angioplasty for critical limb ischemia: Relation of TransAtlantic InterSociety Consensus class to outcome in 176 limbs  Kristina A. Giles,
Long-Term Outcomes of an Endovascular-First Approach for Diabetic Patients With Predominantly Tibial Disease  Caitlin W. Hicks, MD, MS, Joseph K. Canner,
Endovascular-first approach is not associated with worse amputation-free survival in appropriately selected patients with critical limb ischemia  Karan.
Improved Long-Term Survival for Diabetic Patients With Surgical Versus Interventional Revascularization  Paul Kurlansky, MD, Morley Herbert, PhD, Syma.
Defining utility and predicting outcome of cadaveric lower extremity bypass grafts in patients with critical limb ischemia  Catherine K. Chang, MD, Salvatore.
Outcomes of cold-stored venous allograft for below-knee bypasses in patients with critical limb ischemia  Vincent Ziza, MD, Ludovic Canaud, MD, PhD, Thomas.
Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease  Joseph P. Archie, PhD, MD  Journal of Vascular.
Prior failed ipsilateral percutaneous endovascular intervention in patients with critical limb ischemia predicts poor outcome after lower extremity bypass 
Presentation transcript:

Comparative effectiveness of peripheral vascular intervention versus surgical bypass for critical limb ischemia in the Vascular Study Group of Greater New York  Andrew J. Meltzer, MD, Art Sedrakyan, MD, PhD, Abby Isaacs, MS, Peter H. Connolly, MD, Darren B. Schneider, MD  Journal of Vascular Surgery  Volume 64, Issue 5, Pages 1320-1326.e2 (November 2016) DOI: 10.1016/j.jvs.2016.02.069 Copyright © 2016 Society for Vascular Surgery Terms and Conditions

Supplementary Fig (online only) Time to event for limb salvage (LS), reintervention, above-ankle amputation, and restenosis (RAS), reintervention and above-ankle amputation (RAO), overall survival (OS), amputation-free survival (AFS), and major adverse limb event and postoperative death (MALE+POD) for patients undergoing bypass grafting (BPG) or peripheral vascular intervention (PVI). Left, Unmatched cohort. Right, Propensity-score matched cohort. Journal of Vascular Surgery 2016 64, 1320-1326.e2DOI: (10.1016/j.jvs.2016.02.069) Copyright © 2016 Society for Vascular Surgery Terms and Conditions

Supplementary Fig (online only) Time to event for limb salvage (LS), reintervention, above-ankle amputation, and restenosis (RAS), reintervention and above-ankle amputation (RAO), overall survival (OS), amputation-free survival (AFS), and major adverse limb event and postoperative death (MALE+POD) for patients undergoing bypass grafting (BPG) or peripheral vascular intervention (PVI). Left, Unmatched cohort. Right, Propensity-score matched cohort. Journal of Vascular Surgery 2016 64, 1320-1326.e2DOI: (10.1016/j.jvs.2016.02.069) Copyright © 2016 Society for Vascular Surgery Terms and Conditions